Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has received “promising” early results from its wholly owned psychedelics subsidiary Halucenex Life Sciences Inc. s.
Moderna has dosed the first patients in its study of modified COVID-19 vaccines, designed to address the potential need for vaccine booster candidates.